For weight management in people without diabetes , NICE recommends considering semaglutide 2.4 mg (Wegovy) for adults with a BMI 35 kg/m (or lower thresholds for certain ethnic groups) and at least one weight-related comorbidity
A recent high-profile study found that elevated oxidative stress is a shared molecular feature of both conditions, specifically causing immune CD8 T-cells to become functionally exhausted and hyperproliferative
Researchers thought these signs related to the females reduced food intake and body weight
This translates to approximately 40-50 pounds for a 220-pound individual, though actual results depend heavily on starting weight and metabolic factors
With tirzepatide, there is now one GIP/GLP-1 receptor dual agonist with a promising development that may find a prominent place in the treatment algorithm for the therapy of T2D and possibly also for obesity
In the USA we supply to New York, New Jersey, Long Beach California and Los Angeles